Cassava Sciences Inc (SAVA)
2.34
-0.07
(-2.90%)
USD |
NASDAQ |
Dec 24, 16:00
Cassava Sciences Cash and Short Term Investments (Quarterly): 148.98M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 8.094B |
BridgeBio Pharma Inc | 266.32M |
Seelos Therapeutics Inc | 0.294M |
Alnylam Pharmaceuticals Inc | 2.780B |
EyePoint Pharmaceuticals Inc | 253.79M |